No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
No Data
Aura Biosciences Inc (AURA) Reports Q1 2024 Earnings: A Detailed Financial Overview
Scotiabank Remains a Buy on Aura Biosciences Inc (AURA)
Aura Biosciences: A Strong Buy on Promising Clinical Trials and Market Potential
Aura Biosciences: A Strong Buy on Promising Cancer Treatments and Solid Financials
Aura Biosciences | 10-Q: Quarterly report
Express News | Aura Biosciences Inc: Strong Cash Position Expected to Fund Operations Into Second Half of 2026